RealDealDocs - Find thousands of real agreements and clauses from top US law firms

View Clause Headings                                                                                                                                               HelpHelp
DOCUMENT TITLE:  PRODUCT DEVELOPMENT AND LICENSE AGREEMENT .
ACTIONS: Here are the clause headings in the document. To view the clause, click the clause heading.To view the full document, click the "View Document" button.

View Document Back
Clause Heading
2.1 - Joint Steering Committee.
2.2 - Working Groups.
2.3 - Membership.
2.4 - Decision-Making.
2.5 - Meetings of the JSC and Working Groups.
2.6 - Alliance Managers.
2.7 - Third Party Performance of Agreement Activities.
3.1 - Dyax Grants.
3.2 - Grant Back License.
3.3 - Retained Rights.
3.5 - Scope of Agreement; Activities in the Dyax Territory.
3.6 - Right of Second Offer; China.
4.1 - HAE Development Plan.
4.2 - Development Plan for Other Angioedema Indications.
4.3 - Roles and Responsibilities.
4.4 - Diligent Development Efforts
4.5 - Manner of Performance; Reports.
4.6 - Exchange of Development Information.
4.7 - Regulatory Submissions and Regulatory Approvals.
4.8 - Complaints; Adverse Event Reporting Procedures; Notice of Adverse Events Affecting Compound.
4.9 - Audits.
5.2 - Advertising and Promotional Materials.
5.3 - Sales and Distribution.
5.4 - Cross-Territory and Cross-Field Sales.
5.5 - Recalls and Market Withdrawals.
6.1 - Manufacture of Drug Substance and Drug Product.
6.2 - Quality.
6.3 - Responsibility for Product Manufacturing Process.
6.4 - Step-in Rights.
6.5 - Supply and Quality Agreements.
7.1 - License Fee.
7.3 - Ongoing Costs.
7.4 - Sales Milestones.
7.5 - Royalties.
7.6 - Net Sales Reports and Royalty Payments.
7.7 - Audits.
7.8 - Taxes; Deductions and Set-Offs.
7.9 - United States Dollars.
7.10 - Currency Exchange.
7.11 - Blocked Payments.
7.12 - Late Payments.
8.1 - Ownership of Inventions.
(d) - Inventorship; Implementation of Joint Ownership.
8.2 - Prosecution and Maintenance of Patent Rights.
8.3 - Third Party Infringement.
8.4 - Claimed Infringement; Patent Invalidity Claims.
8.5 - Patent Term Extensions.
8.6 - Non-Patent Regulatory Exclusivity.
8.7 - Patent Marking.
8.8 - Trademarks.
9.1 - Confidential Information.
9.2 - Related Party, Employee, Consultant and Advisor Obligations.
9.3 - Publicity; Terms of Agreement.
9.4 - Publications.
10.1 - Representations of Authority.
10.2 - Consents.
10.3 - No Conflict.
10.4 - Enforceability.
10.5 - No Debarment.
10.6 - Additional Representations and Warranties of Dyax.
10.7 - No Warranties.
11.1 - By CMIC.
11.2 - By Dyax.
11.4 - No Consequential or Punitive Damages.
11.5 - Product Liability Insurance.
12.1 - Term.
12.2 - Termination Rights.
12.3 - Consequences of Termination.
12.4 - Survival.
13.1 - Referral to Executive Officers.
13.2 - Final Decision-Making Authority Allocated to a Single Party.
13.3 - Arbitration.
14.1 - Choice of Law; Jurisdiction.
14.2 - Notices.
14.3 - Construction.
14.4 - Severability.
14.5 - Captions.
14.6 - Integration.
14.7 - Independent Contractors; No Agency.
14.8 - Assignment; Successors.
14.9 - Execution in Counterparts; Facsimile Signatures.
14.10 - Waiver.
14.11 - Performance by Affiliates.
14.12 - Force Majeure.
14.13 - Export Control.
14.14 - Costs.